|4Jan 9, 5:01 PM ET

Cahill Brian Joseph 4

4 · EAGLE PHARMACEUTICALS, INC. · Filed Jan 9, 2024

Insider Transaction Report

Form 4
Period: 2024-01-05
Cahill Brian Joseph
Chief Financial Officer
Transactions
  • Tax Payment

    Common Stock

    2024-01-05$5.13/sh735$3,77146,681 total
Footnotes (1)
  • [F1]The disposition reported on this Form 4 represents shares withheld by the Issuer to cover the tax liability upon the vesting of time-based restricted stock units previously granted and does not represent a discretionary transaction by the Reporting Person.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION